Conclusions We observed a lower postoperative mortality rate in the oncology centre compared to the low-volume hospitals; however, this diVerence did not reach statistical signiWcance. We could neither prove a statistically signiWcant relation between hospital volume, local recurrence rate and survival after cystectomy. To answer the question if centralisation of cystectomies is beneWcial more procedures have to be compared.
Introduction
Indicators of outcome after cystectomy (postoperative mortality, recurrence rates and complications) have been compared between high and low-volume surgeons and hospitals in the USA. High-volume surgeons and high-volume hospitals achieve superior outcomes after cystectomy for bladder cancer patients [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . However, deWnitions and thresholds for high-and low-volume are not deWned, and vary from a minimum of three to a minimum of ten. In the USA, the regionalisation of cystectomies is encouraged by a coalition of private and public purchasers of health insurance (Leapfrog group), contrary to the Netherlands [9] . Almost all studies on volume-outcome relation were performed in the USA, and describe the postoperative mortality as indicator of outcome. This is the Wrst study in the Netherlands comparing volume and outcome after cystectomy for bladder cancer. In recent years, a tendency to centralisation of cystectomies, although no part of a consensus policy, has taken place in the greater Amsterdam region. To evaluate the eVects of this centralisation we compared results of an oncology centre with other regional hospitals in the region of the Comprehensive Cancer Centre Amsterdam (CCCA).
Methods

Cancer registry data
All primary bladder tumours diagnosed and treated during 1989-2003 were selected from the CCCA Registry, a population-based cancer registry with complete regional coverage (population 3.0 million). Patients treated with cystectomy were compared with bladder cancer patients treated with cystectomy at the oncology centre. As the number of annual cystectomies in the oncology centre raised from 7 to 21 between 1997 and 1998, this was chosen as cut-oV point for comparison of two periods (1989-1997 and 1998-2003) . Registration clerks extracted demographic data, morphology, stage (TNM) and primary treatment from detailed hospital records. We converted all TNM-data to the sixth version [12] .
Follow-up of vital status
The vital status of all patients was updated by linking the cancer registry to a Wle derived from the national Municipal Population Registry Network comprising all legal Dutch residents who had died or emigrated, as of 1 October 1994 until 1 February 2007. The vital status of patients dying before 1 October 1994 was updated using electronic data Wles, covering 1988-1994, which were made available by the majority of municipal population registries and included all deceased residents irrespective of the cause of death. Completeness of follow-up of vital status is estimated to approximate 100%.
Active follow-up after cystectomy A subset of patients was deWned by selecting patients from the cancer registry who underwent a cystectomy during 1989-2003. Data for 1989-1997 were collected in 2002. For that period data from two small hospitals out of 20 could not be included because one hospital refused permission to extract data from the medical records and because many patient Wles had been destroyed in the other. Data for 1998-2003 were collected in 2006. A supplementary data set which was extracted from the medical records included date of surgery, margins after surgery and the development and date of locoregional recurrence (i.e. recurrence in the soft tissue in the true pelvis). In the second period, the occurrence of distant metastases was also collected in order to be able to distinguish between isolated locoregional recurrences and locoregional recurrence with concomitant metastases.
Follow-up of after cystectomy was minimally 5 years for patients treated until 2002 and minimally 4 and 3 years for patients treated in 2002 and 2003, respectively.
Because active follow-up was not always done at the oncology centre, we cannot guarantee that all recurrences in patients with residence outside the region were known to our registry. Therefore, patients referred to the oncology centre but living outside of the CCCA region were not included in the analysis of locoregional recurrence and survival after cystectomy.
Statistical methods
All statistics were performed in STATA, version 9.0. The postoperative mortality was compared between the oncology centre and all other hospitals using a Cox-regression analysis, correcting for age groups (<60, 60-74, 75 years or older) and sex. The relative risk of developing a locoregional recurrence and risk of death were analysed using a Cox-regression model. The model included the following variables: sex, morphology, T-stage, N-stage, margins, hospital type and treatment period. Kaplan-Meier survival curves were also calculated with STATA. Survival analysis after local recurrence included only patients surviving a minimum of 3 months after cystectomy.
Results
Centralisation and number of cystectomies per hospital
During 1989-2003, a total of 1,185 cystectomies were performed in the 20 hospitals of the CCCA region. Table 1 shows that between 1989 and 1997 cystectomies were performed in all hospitals, ranging from less than one to a maximum of nine cystectomies/year. Between 1998 and 2003 three hospitals performed more than ten cystectomies/ year. The annual number of cystectomies in the oncology centre increased from 7 (1989-1997) to 30 (1998-2003) . In the most recent years, the proportion of patients with residence in the CCCA region that undergoes cystectomy in the oncology centre has further increased to about 30%.
Postoperative mortality
The postoperative mortality (·30 days after cystectomy) for all hospitals combined was 3.2%, but ranged from 0 to almost 10% (Table 1) . Between 1989 and 2003 the postoperative mortality was 1.8% at the oncology centre compared to 3.5% in all other hospitals combined [Cox-regression analysis, correcting for age group and sex: odds ratio (OR) 0.6; P = ns]. Between 1989 and 1997 postoperative mortality in the oncological centre exceeded the postoperative mortality in the other hospitals (4.0 vs. 2.9%; OR 0.7; P = ns), while during 1998-2003 the percentage decreased in the oncological centre to 1.1% compared to 4.4% in the other hospitals (OR 0.3; P = 0.09). The median age in the oncology centre was signiWcantly lower than in the low-volume hospitals (Table 1) .
Locoregional recurrence
After exclusion of patients with residence outside the CCCA region, stage 0 patients, salvage cystectomies and cases with postoperative mortality, 926 patients remained for the analysis of local recurrence: 122 patients were operated in the oncology centre and 804 in one of the other hospitals (Table 2) . 184 patients (19.9%) developed a locoregional recurrence after cystectomy, including six, more than 5 years after cystectomy. The vast majority (91%) of recurrences occurred within 3 years after cystectomy, 81% within 2 years. Of the patients who underwent surgery during 1989-1997, 102 (21.2%) developed a locoregional recurrence. During 1998-2003, 82 (18.4%) patients developed a locoregional recurrence (HR 0.7, 95% CI 0.5-0.9), including 44 (9.9%) isolated locoregional recurrences with no evidence of concomitant distant metastases. Using the actuarial method to calculate the odds of recurrence, the rates were 25% during 1989-1997 and 21% during [1998] [1999] [2000] [2001] [2002] [2003] .
No statistically signiWcant diVerence in locoregional recurrence rate was observed between the oncology centre (18.9%) and all other hospitals combined (20%) (HR 0.9, 95% CI 0.5-1.4). In a sub-analysis of the second period (1998) (1999) (2000) (2001) (2002) (2003) , we compared the risk of isolated locoregional recurrence (i.e. in the absence of concomitant distant metastasis) between various hospital types. In high-volume hospitals (>10 cystectomies/year; three hospitals), intermediate volume (5-10; two hospitals) and low volume (<5; 13 hospitals) stratiWed for sex, morphology, T-stage, N-stage and margins, no statistically diVerent risk of local recurrence was observed [>10 (reference) = 1; 5-10 h = 0.9; <5 h = 0.8].
Survival after cystectomy
The 1-, 3-and 5-year survival after cystectomy was 79, 56 and 47%, respectively. 5-year survival after locoregional recurrence was only 12%. In a multivariate Cox-regression model, the following variables were independent prognosticators for locoregional recurrence and relative risk of death: T-stage, N-stage, margins, morphology and treatment period.
Discussion
Relation between volume and outcome Many studies on the association of volume and outcome after cancer surgery have been performed. In most of them, the relation between volume and short term outcome is strong and consistent, especially for high-risk cancer surgery [6, 13, 14] . A recent study comparing hospital characteristics between low-and high-volume hospitals in the USA showed that diVerences in the processes of care play an important role in postoperative mortality. Hospital capacity, staYng level, clinical services, diagnostic and interventional health services were at a considerably lower level at low-volume hospitals as compared to high-volume centres [7] . All these hospital-related diVerences inXuence morbidity and postoperative mortality. Despite this evidence, the underlying mechanisms of the volume outcome relation still remain unclear [7, 9] . This is further illustrated by Dutch studies comparing survival after surgery for oesophageal and pancreatic cancer in low-and high-volume hospitals, showing contradictory results [15] [16] [17] . The minimum number of cystectomies one should perform to achieve the best outcome is diYcult to determine. Neither the literature nor this study can answer this question. In this study, the total number of cystectomies was analysed, not the number of cystectomies per surgeon. Others have tried to determine the optimum caseload per surgeon. In the UK, an optimum cut-oV value of eight cystectomies per year per surgeon was found [1] . However, cut-oV values for low-and high-volume hospitals and surgeons seem arbitrary and vary in diVerent studies [1, 5, 8, 9, 11] . With a mortality rate between 0.5 and 5.5% and a morbidity rate from 22 to 57%, cystectomy is considered a high-risk procedure [18] . These Wndings have led to centralisation of such procedures in the USA [9, 19] . Although no part of a consensus policy in the greater Amsterdam region, there seems to be a tendency to centralisation, demonstrated by the rise in the annual percentage of cystectomies performed at the oncology centre in relation to the total number of cystectomies. Especially between 1997 and 1998, the annual number of cystectomies rose from 7 to 21 and increased to 30 from that moment on. This swift increase was the result of the expansion of the urology department in the oncology centre. At this moment, 30% of cystectomies in the Greater Amsterdam region and almost 10% of the total number of cystectomies in the Netherlands is being performed at the oncology centre.
Postoperative mortality
We found an overall postoperative mortality of 3.2% in range with most recent studies (0.5-5.5%) [9, 13, 14, [19] [20] [21] [22] .
Like in most studies, we observed a lower postoperative mortality rate in the oncology centre compared to other hospitals, especially in the second period of our study, after an increase of annual cystectomies, although this diVerence was not statistically signiWcant.
The median age at cystectomy was lower in the oncology centre as compared to the other hospitals. While this may cause better outcome Wgures, the relation between age and postoperative mortality in cystectomy is not so strong as compared to gastric and oesophageal cancer procedures [15] [16] [17] . Recently, May et al. [23] compared the outcomes of patients younger than 75 years and older than 75 years at the time of cystectomy. They found no diVerence in perioperative mortality [23] . Other reports conWrm their Wndings [24, 25] . Comorbidity could be of utmost importance [21] . However, in this populationbased comparison between the two hospital types comorbidity should not play a role, because one would expect that comorbidity is equally distributed between all bladder cancer patients in the CCCA region treated with cystectomy. However, if selective referral of patients with more comorbidity from community hospitals to the oncology centre occurred (as we expect), then the postoperative mortality would be higher in the centre. In contrast, the postoperative mortality was lower in the centre as compared to the community hospitals.
In three other hospitals also more than ten cystectomies/ year were performed, and these hospitals might be categorised as high volume according to the literature [6] . In two out of these three hospitals, postoperative mortality remained the same during the whole study period. In the oncology centre, a lower postoperative mortality was seen for the second period when 30 cystectomies/year were performed. Many changes were introduced at the oncology centre after the Wrst period, including standardised postoperative care, direct postoperative enteral feeding and no bowel preparation. Whether these changes are responsible for the diVerence can only be assessed by in depth analysis of hospital-and surgeon-related factors, which is beyond the scope of this analysis.
Local recurrence and survival after cystectomy DiVerences in deWnition of local recurrence make it hard to compare recurrence rates between studies [26] . We found an isolated local recurrence rate of 10% in range with most reports (4-25%) [27, 28] . When we look at the overall local recurrence rate with concomitant distant metastases, this percentage was 19.7%. In patients with a T3 or T4 tumour, the local recurrence rate was even higher, 26.6 and 33.3%, respectively.
A 3% reduction in overall local recurrence rate was observed between the Wrst and second periods (HR 0.7, 0.5-0.9). Perioperative chemotherapy (3.3% of patients during 1989-1997; 6.5% of patients during 1998-2003) might have inXuenced the risk of developing a local recurrence in our series. However, because only a few patients (32 neoadjuvants, 14 adjuvants) received this treatment, no separate analysis was possible.
In the second period, more patients with stage IV bladder cancer were treated with chemotherapy only instead of cystectomy which might explain the lower locoregional recurrence rate after cystectomy in the second period. Stage migration between the Wrst and second periods might play an additional role in the lower locoregional recurrence rate in the second period. In the second period, the number of stage III/IV patients increased due to better staging modalities. When correcting the locoregional recurrence rate for stage in the Cox-regression model, the overall (all stages) recurrence rate decreased because of better stratiWcation in the various stages.
We found no signiWcant diVerence between the oncology centre and the other hospitals regarding the risk of developing local recurrence. When we compared low (<5 cystectomies/year), intermediate (5-10 cystectomies/year) and high-volume hospitals (>10 cystectomies/year), again no signiWcant diVerence on local recurrence was observed.
In contrast to the comparison of short-term outcomes after cystectomy, there is only one study that reports of the association between volume (hospital or surgeon) and longterm outcome. No signiWcant relation between urologist (low volume) and urologic oncologist (high volume) and risk of local recurrence after cystectomy was found [10] . One of the limitations of our study is that we do not have information about the number of cystectomies per surgeon. Volume-related diVerences in survival after cystectomy are small compared to other cancer surgery, so large numbers of patients are needed to Wnd a diVerence [6] . Just recently a study was published comparing low-and high-volume hospitals and survival after cystectomy. 5-year survival rates after cystectomy between low-and high-volume hospitals were 35 and 39%, respectively [6] .
In theory, local recurrence and mortality might be good indirect indicators of quality of surgery because they are more likely to be dependent on the skills' and experience of the individual surgeon than on hospital-related factors [7] . Here again, with small diVerences, much larger number of procedures have to be compared to Wnd statistically signiWcant diVerences. In our opinion, hospital-related factors could be as important as surgeon-related factors in the case of cystectomy. Moreover, these factors are related to each other. This is underscored by the literature, showing higher number of cystectomies being done in larger (semi)academic hospitals, having more technical and personal resources.
Conclusion
We observed a lower postoperative mortality rate in the oncology centre compared to the low-volume hospitals, but this diVerence did not reach statistical signiWcance. We could neither prove a statistical signiWcant relation between hospital volume, local recurrence rate and survival after cystectomy. More procedures have to be compared to prove or refute the advantages of centralisation of cystectomy.
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